Earnings History Data for Orchestra BioMed Holdings, Inc. (OBIO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Orchestra BioMed Holdings, Inc.
Orchestra BioMed Inc. is a biomedical company accelerating high-impact technologies to patients. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy(TM)for the treatment of hypertension and Virtue(R) Sirolimus AngioInfusion(TM) Balloon for the treatment of atherosclerotic artery disease. Orchestra BioMed Inc., formerly known as Health Sciences Acquisitions Corporation 2, is based in NEW HOPE, Pa.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-08-2024 | AH | OBIO | Orchestra BioMed Holdings, Inc. | 237.00 | -0.45 | -0.41 | 0.00 | Orchestra BioMed reports Q2 results [8/13/2024 11:06 AM] |
5.90 | -0.21 (-3.44%) |
6.11 | 0.0 (0.00%) |
4.22 - 11.69 | 36,476 | 70,000 | 4,716 | ||
| 27-03-2024 | AH | OBIO | Orchestra BioMed Holdings, Inc. | 179.00 | -0.37 | -0.38 | 0.00 | Orchestra BioMed reports FY results [3/27/2024 4:52 PM] |
5.32 | 0.02 (0.28%) |
5.20 | -0.10 (-1.98%) |
4.26 - 23.39 | 41,434 | 50,000 | 2,974 | ||
| 13-11-2023 | PM | OBIO | Orchestra BioMed Holdings, Inc. | 186.00 | -0.38 | -0.39 | 0.00 | Orchestra BioMed GAAP EPS of -$0.38 beats by $0.04, revenue of $0.42M [11/14/2023 3:00 AM] |
6.81 | 0.77 (12.75%) |
5.92 | -0.12 (-1.99%) |
4.26 - 23.39 | 44,488 | 40,000 | 1,508 | ||
| 12-05-2023 | PM | OBIO | Orchestra BioMed Holdings, Inc. | 192.00 | -0.40 | -0.23 | 0.00 | Orchestra BioMed GAAP EPS of -$0.40 misses by $0.12, revenue of $1.16M beats by $0.48M [5/12/2023 9:52 AM] |
16.78 | -0.22 (-1.29%) |
0.0 | 0.0 (0.00%) |
7.49 - 23.39 | 55,688 | 30,000 | 0 | ||